Extensively drug-resistant pseudomonas aeruginosa bacteremia in solid organ transplant recipients

Transplantation

Volumn 99, Issue 3, 2015, Pages 616-622

  Bodro, Marta ^a   Sabé, Núria ^a   Tubau, Fe ^a   Lladó, Laura ^a   Baliellas, Carme ^a   González Costello, José ^a   Cruzado, Josep Maria ^a   Carratalà, Jordi ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; FATALITY; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; NONHUMAN; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RESPIRATORY FAILURE; RISK FACTOR; SEPTIC SHOCK; AGED; DRUG EFFECTS; GRAFT RECIPIENT; MULTIDRUG RESISTANCE; PATHOLOGY; TREATMENT OUTCOME;

AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; RISK FACTORS; TRANSPLANT RECIPIENTS; TREATMENT OUTCOME;

EID: 84930518742     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000366     Document Type: Article

References (41)

1. Moreno A, Cervera C, Gavalda J, Bloodstream infections among transplant recipients: results of a nationwide surveillance in Spain. Am J Transplant 2007; 7: 2579
2. Hsu RB, Chang CI, Fang CT, Bloodstream infection in heart transplant recipients: 12-year experience at a university hospital in Taiwan. Eur J Cardiothorac Surg 2011; 40: 1362
3. Singh N, Wagener MM, Obman A, Bacteremias in liver transplant recipients: shift toward gram-negative bacteria as predominant pathogens. Liver Transpl 2004; 10: 844
4. Singh N, Paterson DL, Gayowski T, Predicting bacteremia and bacteremic mortality in liver transplant recipients. Liver Transpl 2000; 6: 54
5. Al-Hasan MN, Razonable RR, Eckel-Passow JE, Incidence rate and outcome of Gram-negative bloodstream infection in solid organ transplant recipients. Am J Transplant 2009; 9: 835
6. Bert F, Larroque B, Paugam-Burtz C, Microbial epidemiology and outcome of bloodstream infections in liver transplant recipients: an analysis of 259 episodes. Liver Transpl 2010; 16: 393
7. Singh N, Gayowski T, Rihs JD, Evolving trends in multiple-antibiotic-resistant bacteria in liver transplant recipients: a longitudinal study of antimicrobial susceptibility patterns. Liver Transpl 2001; 7: 22
8. Johnson LE, D'Agata EM, Paterson DL, Pseudomonas aeruginosa bacteremia over a 10-year period: multidrug resistance and outcomes in transplant recipients. Transpl Infect Dis 2009; 11: 227
9. Linares L, Cervera C, Cofan F, Risk factors for infection with extended-spectrum and AmpC beta-lactamase-producing gram-negative rods in renal transplantation. Am J Transplant 2008; 8: 1000
10. Linares L, Cervera C, Cofan F, Epidemiology and outcomes of multiple antibiotic-resistant bacterial infection in renal transplantation. Transplant Proc 2007; 39: 2222
11. Shi SH, Kong HS, Xu J, Multidrug resistant gram-negative bacilli as predominant bacteremic pathogens in liver transplant recipients. Transpl Infect Dis 2009; 11: 405
12. van Duin D, van Delden C,. Multidrug-resistant gram-negative bacteria infections in solid organ transplantation. Am J Transplant 2013; 13 (Suppl 4): 31
13. Canton R, Akova M, Carmeli Y, Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect 2012; 18: 413
14. Schwaber MJ, Carmeli Y,. Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother 2007; 60: 913
15. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008; 52: 1028
16. Caselli D, Cesaro S, Ziino O, Multidrug resistant Pseudomonas aeruginosa infection in children undergoing chemotherapy and hematopoietic stem cell transplantation. Haematologica 2010; 95: 1612
17. Linares L, Garcia-Goez JF, Cervera C, Early bacteremia after solid organ transplantation. Transplant Proc 2009; 41: 2262
18. Shi SH, Kong HS, Jia CK, Risk factors for pneumonia caused by multidrug-resistant gram-negative bacilli among liver recipients. Clin Transplant 2010; 24: 758
19. Hoyo I, Linares L, Cervera C, Epidemiology of pneumonia in kidney transplantation. Transplant Proc 2010; 42: 2938
20. Suarez C, Pena C, Arch O, A large sustained endemic outbreak of multiresistant Pseudomonas aeruginosa: a new epidemiological scenario for nosocomial acquisition. BMC Infect Dis 2011; 11: 272
21. Mulet X, Cabot G, Ocampo-Sosa AA, Biological markers of Pseudomonas aeruginosa epidemic high-risk clones. Antimicrob Agents Chemother 2013; 57: 5527
22. Pena C, Suarez C, Tubau F, Nosocomial outbreak of a non-cefepime-susceptible ceftazidime-susceptible Pseudomonas aeruginosa strain overexpressing MexXY-OprM and producing an integron-borne PSE-1 betta-lactamase. J Clin Microbiol 2009; 47: 2381
23. Cabot G, Ocampo-Sosa AA, Dominguez MA, Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones. Antimicrob Agents Chemother 2012; 56: 6349
24. Averbuch D, Cordonnier C, Livermore DM, Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011). Haematologica 2013; 98: 1836
25. Souli M, Galani I, Boukovalas S, In vitro interactions of antimicrobial combinations with fosfomycin against KPC-2-producing Klebsiella pneumoniae and protection of resistance development. Antimicrob Agents Chemother 2011; 55: 2395
26. Elemam A, Rahimian J, Doymaz M,. In vitro evaluation of antibiotic synergy for polymyxin B-resistant carbapenemase-producing Klebsiella pneumoniae. J Clin Microbiol 2010; 48: 3558
27. Moriyama B, Henning SA, Childs R, High-dose continuous infusion beta-lactam antibiotics for the treatment of resistant Pseudomonas aeruginosa infections in immunocompromised patients. Ann Pharmacother 2010; 44: 929
28. Gudiol C, Calatayud L, Garcia-Vidal C, Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome. J Antimicrob Chemother 2010; 65: 333
29. Gudiol C, Tubau F, Calatayud L, Bacteraemia due to multidrug-resistant gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes. J Antimicrob Chemother 2011; 66: 657
30. Pena C, Suarez C, Gozalo M, Prospective multicenter study of the impact of carbapenem resistance on mortality in Pseudomonas aeruginosa bloodstream infections. Antimicrob Agents Chemother 2012; 56: 1265
31. Hodson EM, Jones CA, Webster AC, Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials. Lancet 2005; 365: 2105
32. Bodro M, Sabe N, Tubau F, Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients. Transplantation 2013; 96: 843
33. Tacconelli E, Cataldo MA, Dancer SJ, ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant gram-negative bacteria in hospitalized patients. Clin Microbiol Infect 2014; 20 (Suppl 1): 1
34. Magiorakos AP, Srinivasan A, Carey RB, Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18: 268
35. Friedman ND, Kaye KS, Stout JE, Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002; 137: 791
36. Dalfino L, Puntillo F, Mosca A, High-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary study. Clin Infect Dis 2012; 54: 1720
37. Luque S, Grau S, Valle M, Differences in pharmacokinetics and pharmacodynamics of colistimethate sodium (CMS) and colistin between three different CMS dosage regimens in a critically ill patient infected by a multidrug-resistant Acinetobacter baumannii. Int J Antimicrob Agents 2013; 42: 178
38. Clinical and Laboratory Sandards Institute (Formerly NCCLS). Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Third Informational Supplement. CLSI document M100-S23 Vol 33 No.1 [ISBN 1-56238-588-7] Clinical and Laboratory Standards Institute; 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 US, 2013. 2013
39. Deplano A, Denis O, Poirel L, Molecular characterization of an epidemic clone of panantibiotic-resistant Pseudomonas aeruginosa. J Clin Microbiol 2005; 43: 1198
40. Tenover FC, Arbeit RD, Goering RV, Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233
41. van Belkum A, Tassios PT, Dijkshoorn L, Guidelines for the validation and application of typing methods for use in bacterial epidemiology. Clin Microbiol Infect 2007; 13 (Suppl 3): 1